![]() |
市場調査レポート
商品コード
1535079
百日咳検査市場:セグメント別規模、シェア、法規制、償還、2033年までの予測Bordetella pertussis (Whooping Cough) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 |
||||||
カスタマイズ可能
適宜更新あり
|
百日咳検査市場:セグメント別規模、シェア、法規制、償還、2033年までの予測 |
出版日: 2024年05月27日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
![]() |
ボルデテラ・パーツシスとも呼ばれる百日咳は、百日咳菌によって引き起こされる上気道感染症です。この病気は、感染者が咳やくしゃみをしたときに細菌の小さな飛沫を吸い込むことによって人から人へと広がります。百日咳菌は肺に入り、気道の上部に付着して毒素を放出し、腫れや刺激により過剰な咳を引き起こします。
当レポートは、世界の百日咳検査市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、地域、国別の動向などを提供しています。
Bordetella pertussis (Whooping Cough) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.
Bordetella pertussis, also called whooping cough, is an upper respiratory infectious disease caused by Bordetella pertussis bacteria. The disease spreads person to person by inhaling the tiny droplets of bacteria when an infected person coughs or sneezes. The B. pertussis bacteria enters the lungs, attaches to the upper part of the respiratory tract and releases toxins, which cause excessive coughing due to swelling and irritation.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Bordetella pertussis (Whooping Cough) Tests and evolving competitive landscape:
2015- 2033.
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Meridian Biosciences Inc, Hologic Inc, bioMerieux SA, Luminex Corp, Quidelortho Corp, Tecan Group Ltd, STAT-Dx, Euroimmun AG, and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -